\nNEW FILINGS<\/p>\n
Company: Ping Identity Holding Corp.
\nSymbol: PING
\nDescription: Ping is pioneering Intelligent Identity. They enable secure access to any service, application or API from any device.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Goldman Sachs, BofA Merrill Lynch, RBC Capital, Citigroup, Barclays, Credit Suisse, Deutsche Bank, Wells Fargo
\nCo-Manager(s): Raymond James, Stifel, William Blair, Mizuho Securities, Oppenheimer
\nFiled: 8-23-19
\nListed Cash Raise: $100m<\/p>\n
Company: IGM Biosciences, Inc.
\nSymbol: IGMS
\nDescription: They are a biotechnology company pioneering the development of engineered IgM antibodies for the treatment of cancer patients.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Jefferies, Piper Jaffray, Stifel, Guggenheim Securities
\nFiled: 8-19-19
\nListed Cash Raise: $100m<\/p>\n
Company: 10x Genomics, Inc.
\nSymbol: TXG
\nDescription: They are a life science technology company building products to interrogate, understand and master biology.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): JP Morgan, Goldman Sachs, BofA Merrill Lynch
\nCo-manager(s): Cowen
\nFiled: 8-19-19
\nListed Cash Raise: $100m<\/p>\n
Company: Alerus Financial Corporation
\nSymbol: ALRS
\nDescription: They are a diversified financial services company headquartered in Grand Forks, North Dakota.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Raymond James, DA Davidson
\nCo-Manager: Piper Jaffray
\nFiled: 8-16-19
\nListed Cash Raise: $75m<\/p>\n
Company: Satsuma Pharmaceuticals, Inc.
\nSymbol: STSA
\nDescription: They are a clinical-stage biopharmaceutical company developing a novel therapeutic product for the acute treatment of migraine.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Credit Suisse, SVB Leerink, Evercore ISI
\nFiled: 8-16-19
\nListed Cash Raise: $86.25m<\/p>\n
Company: SpringWorks Therapeutics, Inc.
\nSymbol: SWTX
\nDescription: They are a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): JP Morgan, Goldman Sachs, Cowen
\nCo-Manager: Wedbush PacGrow
\nFiled: 8-16-19
\nListed Cash Raise: $115m<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24,1536],"tags":[],"class_list":["post-9734","post","type-post","status-publish","format-standard","hentry","category-ipo","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/9734","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=9734"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/9734\/revisions"}],"predecessor-version":[{"id":9735,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/9734\/revisions\/9735"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=9734"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=9734"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=9734"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}